City Holding Co’s Halozyme HALO Stock Holding History

City Holding Co’s Portfolio HALO Stock Details HALO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-184	Closed	-$11.7K	–	544
2025 Q1	$11.7K	Buy	+184	New	+$10.7K	﹤0.01%	468

Other funds holding HALO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

SCM

Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

City Holding Co's HALO Position: Q2 2025 in Review

City Holding Co sold out of Halozyme (HALO) in Q2 2025, closing a stake of 184 shares — an estimated $11.7K sold.

City Holding Co first reported a position in HALO in Q1 2025 and held it in 1 quarter. The position peaked at $11.7K in Q1 2025. 551 funds tracked by Wall St. Rank hold HALO as of Q2 2025.

City Holding Co reported no remaining Halozyme position as of Q2 2025 after selling out during the quarter.
City Holding Co sold 184 Halozyme shares in Q2 2025, an estimated $11.7K.
City Holding Co first reported a position in Halozyme in Q1 2025 and held it in 1 quarter.
City Holding Co's Halozyme position peaked at $11.7K in Q1 2025.
551 funds tracked by Wall St. Rank held Halozyme as of Q2 2025.

Based on City Holding Co's 13F filing for Q2 2025, filed 17 Jul 2025.